A patient-centered gout information value chain: a scoping review

被引:1
作者
Russell, Maranda J. [1 ,2 ]
Kim, Sujin [2 ,3 ]
Lenert, Aleksander [4 ]
机构
[1] Univ Kentucky, Coll Med, Coll Commun & Informat Coll Med, Dept Commun, Lexington, KY 40506 USA
[2] Univ Kentucky, Coll Med, Div Biomed Informat, Lexington, KY 40506 USA
[3] Univ Kentucky, Coll Commun & Informat, Sch Informat Sci, Lexington, KY 40506 USA
[4] Univ Iowa, Carver Coll Med, Div Immunol, Iowa City, IA 52242 USA
关键词
OF-RHEUMATOLOGY GUIDELINES; CARE; MANAGEMENT; URATE; ADHERENCE; EDUCATION; PREVALENCE; KNOWLEDGE; BARRIERS; THERAPY;
D O I
10.1016/j.pec.2021.06.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To examine and identify the scope of research addressing health information requirements for gout patients using value chain analysis. Methods: Five electronic databases (PubMed, CINAHL, ERIC, PsycINFO, Embase, and Scopus) and grey literature (WorldCat) were searched in accordance with a published protocol. Only English language articles were included, with no limitations for date of publication. The findings of the 33 studies included for final analysis were subsequently divided into 6 groups according to the stages of the care delivery value chain their research most closely pertained to: screening/preventing (n = 2), diagnosing (n = 1), preparing (n = 7), intervening (n = 11), recovering/rehabilitating (n = 5), and monitoring/managing (n = 13). Results: The 33 studies focused on one or more of the following information phenotypes: 1) pathophysiology; 2) medical treatment; and 3) nonpharmaceutical interventions. Long term treatment adherence was a popular topic amongst studies that focused on gout patient education. Conclusion: Based on the identified studies, gout patients are being told what to do, but are not being adequately educated regarding why recommended interventions are important or how to accomplish them. Practice implications: This review provides a foundation to develop and evaluate personalized education materials using value chain analysis. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页码:30 / 43
页数:14
相关论文
共 47 条
  • [1] Education and non-pharmacological approaches for gout
    Abhishek, Abhishek
    Doherty, Michael
    [J]. RHEUMATOLOGY, 2018, 57 : i51 - i58
  • [2] Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study
    Abhishek, Abhishek
    Jenkins, Wendy
    La-Crette, Jonathan
    Fernandes, Gwen
    Doherty, Michael
    [J]. RHEUMATOLOGY, 2017, 56 (04) : 529 - 533
  • [3] [Anonymous], 2016, Arthritis Rheumatol, V68 Suppl 10, P1, DOI 10.1002/art.39977
  • [4] Atreja Ashish, 2005, MedGenMed, V7, P4
  • [5] Treatment approaches and adherence to urate-lowering therapy for patients with gout
    Aung, Thanda
    Myung, Gihyun
    FitzGerald, John D.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 795 - 800
  • [6] We can make gout management more successful now
    Becker, Michael A.
    Chohan, Saima
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (02) : 167 - 172
  • [7] Buhlmann S, 2009, CARE DELIVERY VALUE
  • [8] "You want to get on with the rest of your life": a qualitative study of health-related quality of life in gout
    Chandratre, Priyanka
    Mallen, Christian D.
    Roddy, Edward
    Liddle, Jennifer
    Richardson, Jane
    [J]. CLINICAL RHEUMATOLOGY, 2016, 35 (05) : 1197 - 1205
  • [9] Alcohol intake and risk of incident gout in men: a prospective study
    Choi, HK
    Atkinson, K
    Karlson, EW
    Willett, W
    Curhan, G
    [J]. LANCET, 2004, 363 (9417) : 1277 - 1281
  • [10] Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study
    Coburn, Brian W.
    Cheetham, T. Craig
    Rashid, Nazia
    Chang, John M.
    Levy, Gerald D.
    Kerimian, Artak
    Low, Kimberly J.
    Redden, David T.
    Bridges, S. Louis, Jr.
    Saag, Kenneth G.
    Curtis, Jeffrey R.
    Mikuls, Ted R.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2016, 50 : 106 - 115